- Home
- MRUS vs CNK Comparison
MRUS vs CNK Comparison
Compare MRUS & CNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- CNK
- Stock Information
- Founded
- MRUS 2003
- CNK 1984
- Country
- MRUS Netherlands
- CNK United States
- Employees
- MRUS N/A
- CNK N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- CNK Movies/Entertainment
- Sector
- MRUS Health Care
- CNK Consumer Discretionary
- Exchange
- MRUS Nasdaq
- CNK Nasdaq
- Market Cap
- MRUS 2.7B
- CNK 3.2B
- IPO Year
- MRUS 2016
- CNK 2007
- Fundamental
- Price
- MRUS $42.77
- CNK $31.01
- Analyst Decision
- MRUS Strong Buy
- CNK Buy
- Analyst Count
- MRUS 14
- CNK 12
- Target Price
- MRUS $87.00
- CNK $33.00
- AVG Volume (30 Days)
- MRUS 786.0K
- CNK 3.8M
- Earning Date
- MRUS 05-07-2025
- CNK 05-02-2025
- Dividend Yield
- MRUS N/A
- CNK 0.26%
- EPS Growth
- MRUS N/A
- CNK 16.58
- EPS
- MRUS N/A
- CNK 1.71
- Revenue
- MRUS $54,732,000.00
- CNK $3,011,000,000.00
- Revenue This Year
- MRUS $26.81
- CNK $8.71
- Revenue Next Year
- MRUS $23.85
- CNK $7.42
- P/E Ratio
- MRUS N/A
- CNK $18.09
- Revenue Growth
- MRUS N/A
- CNK N/A
- 52 Week Low
- MRUS $33.19
- CNK $16.32
- 52 Week High
- MRUS $61.61
- CNK $36.28
- Technical
- Relative Strength Index (RSI)
- MRUS 49.60
- CNK 70.72
- Support Level
- MRUS $37.92
- CNK $27.86
- Resistance Level
- MRUS $46.36
- CNK $31.57
- Average True Range (ATR)
- MRUS 2.56
- CNK 0.99
- MACD
- MRUS -0.22
- CNK 0.12
- Stochastic Oscillator
- MRUS 57.46
- CNK 84.91
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About CNK Cinemark Holdings Inc Cinemark Holdings Inc.
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.